Sort
15,440 grants matching “organoids”
Mechanisms mediating podocyte-parietal epithelial cell crosstalk in proliferative glomerulopathies
$508,915Sandeep K Mallipattu · State University New York Stony Brook · R01 · FY2023 · DK
Mechanisms mediating podocyte-parietal epithelial cell crosstalk in proliferative glomerulopathies
$508,915Sandeep K Mallipattu · State University New York Stony Brook · R01 · FY2022 · DK
A transdisciplinary approach for dissecting stem cell states in prostate cancer
$508,914Raul Rabadan · Columbia University Health Sciences · U01 · FY2023 · CA
Project 1: Overcoming therapeutic resistance in pancreatic cancer through epigenetic reprogramming
$508,896Ronald M. Evans · Salk Institute For Biological Studies · P01 · FY2023 · CA
Project 1: Overcoming therapeutic resistance in pancreatic cancer through epigenetic reprogramming
$508,895Ronald M. Evans · Salk Institute For Biological Studies · P01 · FY2025 · CA
Defining GATA4's Molecular Function in Gastric Cell Biology
$508,824Michele A Battle · North Carolina State University Raleigh · R01 · FY2024 · DK
The TNF Superfamily Control of Pathological Remodeling Associated with Severe Asthma
$508,584Rana Elias Herro · Cincinnati Childrens Hosp Med Ctr · R01 · FY2023 · AI
Developing a patient-specific organoid model of pulmonary fibrosis using iPSCs
$508,550Darrell N. Kotton · Boston University Medical Campus · U01 · FY2021 · HL
Epstein-Barr Virus Driven Tonsillar Versus Peripheral B-cell One-Carbon Metabolic Network Remodeling
$508,476Benjamin Elison Gewurz · Brigham And Women'S Hospital · R01 · FY2025 · DE
Modeling Factors Associated with Risk of High-Grade Serous Carcinoma in Mice
$508,332Kathleen R. Cho · University Of Michigan At Ann Arbor · R01 · FY2021 · CA
EPHA2 Receptor Signaling in Breast Cancer Mechanotransduction
$508,287Elena B Pasquale · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2024 · CA
Modeling Drug Induced Liver Injury with Patient-Derived Liver Organoids and Microfluidic Chips
$508,057Jonathan Zachary Sexton · University Of Michigan At Ann Arbor · R01 · FY2025 · GM
Modeling Drug Induced Liver Injury with Patient-Derived Liver Organoids and Microfluidic Chips
$508,057Jonathan Zachary Sexton · University Of Michigan At Ann Arbor · R01 · FY2024 · GM
The role of TRIM37 in driving tumorigenesis and cancer-specific vulnerability to PLK4 inhibition
$507,998Sergi Regot · Johns Hopkins University · R01 · FY2025 · CA
Stem Cell-Based Models for Elucidating Human Adrenocortical Development and Dysfunction
$507,829Kotaro Sasaki · University Of Pennsylvania · R01 · FY2023 · DK
A Fully Patterned Human Neural Tube Model Using Microfluidics
$507,741Jianping Fu · University Of Michigan At Ann Arbor · R01 · FY2024 · NS
Deciphering the Molecular Genetics of VSIG10L in Barrett's Neoplasia
$507,720Amitabh Chak · Case Western Reserve University · P01 · FY2024 · CA
Combination Therapies Targeting Insulin Signaling in Endometrial Cancer
$507,696Marcus Dasilva Goncalves · New York University School Of Medicine · R01 · FY2024 · CA
Studying the role of eIF4A in Pancreatic Cancer
$507,629Christine Iok In Chio · Columbia University Health Sciences · R01 · FY2022 · CA
Improving the translational value of head and neck cancer patient-in-mouse models
$507,439Randall J Kimple · University Of Wisconsin-Madison · R37 · FY2023 · CA
Studying roles of CASP8 SVA GGGAGA repeat expansions in Alzheimer's disease
$507,371Lien Nguyen · University Of Florida · R01 · FY2025 · AG
Alzheimer's Disease: simultaneous modulation of NMDAR, BACE1, APP and Fyn activity by palmitoylation-targeting CIRC825
$507,284Devin Thomas Wiley · Circumvent Pharmaceuticals, Inc. · R43 · FY2021 · AG
Biological Basis of Phenotypes and Clinical Outcomes in Biliary Atresia
$507,246Jorge A. Bezerra · Cincinnati Childrens Hosp Med Ctr · R01 · FY2021 · DK
Tissue-specific genetic interactions in cancer
$507,221Kevin Michael Haigis · Beth Israel Deaconess Medical Center · R01 · FY2019 · CA
Decreased SRD5A2 and Alternative Estrogen Signaling in Prostatic Cell Survival
$507,083Aria F Olumi · Beth Israel Deaconess Medical Center · R01 · FY2025 · DK